80707-93-3

Basic information

• Product Name: 1-O-OCTADECYL-2-O-BENZYL-SN-GLYCEROL
• Synonyms: 1-O-OCTADECYL-2-O-BENZYL-SN-GLYCEROL
• CAS NO: 80707-93-3
• Molecular Formula: C₂₈H₅₀O₃
• Molecular Weight: 434.69
• Mol File: 80707-93-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: 1-O-OCTADECYL-2-O-BENZYL-SN-GLYCEROL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-OCTADECYL-2-O-BENZYL-SN-GLYCEROL(80707-93-3)
• EPA Substance Registry System: 1-O-OCTADECYL-2-O-BENZYL-SN-GLYCEROL(80707-93-3)

Safety Data

• Hazardous Substances Data: 80707-93-3(Hazardous Substances Data)

Usage

Classification

Synthetic compound
Belongs to the class of glycerol derivatives

Function

Surfactant and emulsifying agent

Applications

Personal care and cosmetic products
Pharmaceutical formulations

Properties

Stabilizes and emulsifies oil-in-water systems
Solubilizes poorly soluble drugs
Disperses pigments and fillers in cosmetic formulations

Safety

Deemed safe for use in cosmetics and personal care products
Approved by the Cosmetic Ingredient Review Expert Panel

Common products containing OBG

Shampoos
Skin creams
Bath products
Lotions, creams, and ointments

Upstream product

• 112-92-5 1-octadecanol 
• 84379-56-6 1-O-octadecyl-2-O-benzyl-3,4-O-isopropylidene-D-threitol 
• 100-52-7 benzaldehyde 
• 91326-83-9 (4S,5S)-dimethyl 2-phenyl-1,3-dioxolane-4,5-dicarboxylate 
• 84379-52-2 (2R,3R)-3-(benzyloxy)butane-1,2,4-triol 
• 84379-54-4 (R)-2-(benzyloxy)-2-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl]ethanol 
• 31081-59-1 1-octadecyl methanesulfonate 
• 10585-86-1 1,2-Di-O-isopropyliden-3-O-octadecyl-sn-glycerin 
• 83526-60-7 2-O-Acetyl-1-O-benzyl-3-O-octadecyl-sn-glycerin 
• 83526-52-7 3-O-Octadecyl-2-O-p-toluolsulfonyl-sn-glycerin 
• 83526-54-9 3-O-Octadecyl-1-O-p-toluolsulfonyl-sn-glycerin 
• 83537-01-3 (-)-1-O-octadecyl-2-O-acetyl-sn-glycerol 
• 83526-56-1 (S)-1,2-Epoxy-3-(octadecyloxy)propan 
• 83526-51-6 3-O-Octadecyl-2-O-p-toluolsulfonyl-3-O-trityl-sn-glycerin 

Downstream Products

• 80483-86-9 2-O-Benzyl-1-O-octadecyl-sn-glycero-3-phosphorylcholin 
• 1026554-06-2 Phosphoric acid (R)-2-benzyloxy-3-octadecyloxy-propyl ester (S)-2,3-dihydroxy-propyl ester 
• 918946-93-7 Phosphoric acid (R)-2-benzyloxy-3-octadecyloxy-propyl ester (S)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester methyl ester 
• 74430-89-0 Lyso-platelet-activating factor (C₁₈) 
• 74389-69-8 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine 
• 99804-87-2 (R)-2-O-benzyl-1-[(2-bromoethoxy)carbonyl]-3-O-octadecylglycerine 
• 83167-59-3 1-O-octadecyl-2-O-methyl-sn-glycerol 
• 80459-32-1 (2R)-2-Benzyloxy-3-octadecyloxypropyl 2-bromoethyl phosphate 
• 105415-93-8 (R)-2-benzyloxy-3-octadecyloxypropyl 2-(N-methylpyrrolidinio)ethyl phosphate 
• 105435-57-2 (R)-2-benzyloxy-3-octadecyloxypropyl 2-(diethylmethylammonio)ethyl phosphate 
• 99804-98-5 (R)-2-O-benzyl-1-O-[(2-chloroethyl)carbamoyl]-3-O-octadecylglycerine 
• 99804-86-1 (R)-2-O-benzyl-1-O-(4-chlorobutyryl)-3-O-octadecylglycerine 

Relevant articles and documents

Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue

The clinical use of anticancer lipids is severely limited by their ability to cause lysis of red blood cells prohibiting intravenous injection. Novel delivery systems are therefore required in order to develop anticancer ether lipids (AELs) into clinicall

Method of use of 1-(alkyl for alkylcarbanoyl)-2-carbamoylglycerol derivatives

Glycerol derivatives, inclusive of salts thereof, of the formula STR1 wherein R1 is alkyl or alkylcarbamoyl containing 10 to 30 carbon atoms, R2 and R3 are independently hydrogen, C1-6 alkyl or, taken together w

An enantioselective synthesis of platelet-activating factors, their enantiomers, and their analogues from D- and L-tartaric acids

-